Mark Johnson | Senior Director of IR |
Sanjay Shukla | President & CEO |
David King | Chief Scientific Officer |
Joe Broadfoot | Chief Financial Officer |
Ted Tenthoff | Piper Jaffray |
Matthew Glucina | BMO Capital |
Joel Beatty | Citi |
Good morning, ladies and gentlemen, and welcome to the aTyr Pharma Second Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, instructions will be given at that time. [Operator Instructions] As a reminder to our audience, this conference is being recorded for replay purposes. It is now pleasure to hand the conference to Mark Johnson, Senior Director of Investor Relations.